Workshop E: BNT211: A Phase 1/11 Trial to Evaluate Safety & Efficacy of CLDN6 CAR-T & CARVas Based In Vivo Expansion to Improve Treatment of Patients with CLDN6+ Advanced Solid Tumours

Time: 12:00 pm
day: Workshop – Track B – Afternoon


  • Update on preliminary data from Ph1 dose escalation for CLDN6 CAR-T monotherapy and combination with CARVac
  • Introduction of new manufacturing process
  • Insights into exploratory biomarker programme